Vermedx(R) Diabetes Treatment Cost Savings Data Published In American Journal Of Managed Care
Main Category: DiabetesArticle Date: 19 Mar 2009 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The American Journal of Managed Care (AJMC) has published an article describing the experience of Vermont Managed Care, Inc., a physician hospital organization (PHO), in the clinical utilization of the Vermedx Diabetes Information System® (VDIS). The article may be viewed at http://www.ajmc.com.
Participation in the VDIS program is associated with substantial reductions in claims paid as well as measurable treatment quality improvements. Net savings range from $504 per patient in the first year of operations, to $3,563 in the fourth year, according to the AJMC article.
The American Journal of Managed Care is an independent, peer-reviewed publication dedicated to publishing original research in health care outcomes and creating a forum for scientific communication in the ever-evolving field of health care delivery. The journal is indexed in MEDLINE/PUBMED.
"With 40 million Americans affected by diabetes and with related costs exceeding $175 billion annually, we are presented with the difficult challenge of extending quality care to all of our patients while managing the staggering medical costs of this epidemic," said Benjamin Littenberg, MD, CEO of Vermont Clinical Decision Support, LLC, the creators of Vermedx®. "We are delighted Vermont Managed Care, Inc. has independently validated the cost savings and quality of life benefits resulting from the use of our Vermedx Diabetes Information System."
Managed care and provider organizations have been utilizing the Vermedx® Diabetes Information System since 2006. Both the New York City Department of Health and San Antonio Metropolitan Health District are utilizing Vermedx® Registry technology as a core component of their initiatives to assess, monitor and improve diabetes care.
The Vermedx® Diabetes Information System (VDIS) captures laboratory test results from multiple labs and automatically produces population summary reports and "report cards" at regional, community, provider and practice levels. It also produces individual patient-level health status reports with accompanying guideline-based recommendations for care. Managed care organizations cite substantial cost reductions in treating patients who are covered by the Vermedx® system.
About Vermedx®
Vermedx® Disease Management Programs deliver measurable treatment quality improvement, process refinement, and treatment cost-reduction outcomes for chronic disease patients, providers, insurers, and public health agencies. Read the Health Information Exchange Blog at http://healthinfoex.blogspot.com/ and visit http://www.vermedx.com/ for more information.
Source
Vermedx
Visit our diabetes section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/142760.php>
APA
http://www.medicalnewstoday.com/releases/142760.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




